Related Experiment Video
Updated: Jul 7, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Applying heart failure guidelines to adult congenital heart disease patients
1Division of Cardiology, The Children's Hospital of Philadelphia, and University of Pennsylvania School of Medicine, 34th Street and Civic Center Blvd, Philadelphia, PA 19104-4399, USA. shaddyr@email.chop.edu
Insights
Adults with repaired congenital heart defects often have heart dysfunction and exercise intolerance. Current heart failure guidelines may apply to those with a systemic left ventricle, but not those without.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease
- Heart Failure
Background:
- A growing population of adults with congenital heart defects (CHDs) requires ongoing cardiovascular care.
- Many adults with repaired CHDs experience myocardial dysfunction, exercise intolerance, and heart failure.
- Neurohormonal activation in these patients mirrors that seen in acquired heart failure.
Purpose of the Study:
- To review the current state of heart failure management in adults with CHDs.
- To identify patient groups at highest risk for heart failure progression.
- To highlight the need for evidence-based therapeutic strategies for specific CHD populations.
Main Methods:
- Review of existing literature and clinical guidelines for heart failure management.
- Analysis of patient populations with CHDs, categorizing by ventricular support (systemic left vs. non-left ventricle).
- Assessment of exercise intolerance as a predictor of adverse outcomes.
Main Results:
- Patients without a systemic left ventricle (e.g., Mustard/Senning repairs for transposition of the great arteries, Fontan procedure) are at the highest risk for heart failure.
- Exercise intolerance is a significant predictor of hospitalization and mortality in these high-risk CHD populations.
- Established heart failure guidelines for acquired heart disease may be applicable to CHD patients with a systemic left ventricle.
Conclusions:
- Evidence-based therapeutic guidelines are lacking for adult CHD patients without a systemic left ventricle.
- Further research is needed to develop tailored treatment strategies for patients with single ventricle physiology or systemic right ventricles.
- Optimizing management for adults with CHDs requires addressing both ventricular function and systemic circulatory challenges.
Abstract:
There is a growing population of adult patients with congenital heart defects in the developed world. Most have been repaired, but few have been cured. Many have myocardial dysfunction. Most have exercise intolerance. Some have heart failure. As a group, they show neurohormonal activation similar to that seen in an adult heart failure population with acquired heart disease. Currently, the patients at greatest risk of heart failure are those without a systemic left ventricle, such as Mustard and Senning repairs of transposition of the great arteries (TGA), congenitally corrected TGA, and patients who have had a Fontan procedure. Exercise intolerance may predict hospitalization and death in such patients. For those patients with systemic left ventricles, it would seem reasonable to use the heart failure guidelines developed for patients with acquired heart disease. For those patients without a systemic left ventricle (e.g., a systemic right ventricle or single ventricle), there is currently no foundation for evidence-based therapy.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy

